If you could vote on Brexit now which option would you choose?

Celltrion says trial shows antibody COVID-19 treatment to be safe and effective

South Korean drugmaker Celltrion Inc on Monday announced positive results for its experimental antibody COVID-19 treatment that it said was safe and reduced the treatment period by nearly five days in Phase 3 global clinical trials. The trials, which involved 1,315 participants, have taken place since January in 13 countries, including in South Korea, the United States, Spain and Romania, Celltrion said in a statement. The treatment slowed severe symptoms of COVID-19 in more than 70% of patients, including the high-risk group with underlying conditions. It also cut the recovery period by 4.9 days, the company said.

Reuters - June 14, 2021

View the full story here: https://www.reuters.com/business/healthcare-pharmaceuticals/celltrion-says-trial-shows-antibody-covid-19-treatment-be-safe-effective-2021-06-14/